Skip to main content

Advertisement

Log in

Deficiency of SCAMP5 leads to pediatric epilepsy and dysregulation of neurotransmitter release in the brain

  • Original Investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

Secretory carrier membrane proteins (SCAMPs) play an important role in exocytosis in animals, but the precise function of SCAMPs in human disease is unknown. In this study, we identified a homozygous mutation, SCAMP5 R91W, in a Chinese consanguineous family with pediatric epilepsy and juvenile Parkinson’s disease. Scamp5 R91W mutant knock-in mice showed typical early-onset epilepsy similar to that in humans. Single-neuron electrophysiological recordings showed that the R91W mutation significantly increased the frequency of miniature excitatory postsynaptic currents (mEPSCs) at a resting state and also increased the amplitude of evoked EPSCs. The R91W mutation affected the interaction between SCAMP5 and synaptotagmin 1 and may affect the function of the SNARE complex, the machinery required for vesicular trafficking and neurotransmitter release. Our work shows that dysfunction of SCAMP5 shifted the excitation/inhibition balance of the neuronal network in the brain, and the deficiency of SCAMP5 leads to pediatric epilepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Download references

Acknowledgements

We would like thank the family members for their enthusiastic participation in this study. This work is supported by the National Natural Science Foundation of China grants (81000079, 81170165 and 81870959 to X.Z.) and supported by Program for HUST Academic Frontier Youth Team.

Author information

Authors and Affiliations

Authors

Contributions

XQZ leaded and supervised the work and designed the experiments, DZ, XQZ, ML and XY wrote the manuscript. DZ, CY, ML, XPZ, GL, MH, ZL, XW, YT, WJ, JW, YW, AW performed experiments. XY designed the patch-clamp experiments. SG and XW took clinical care of the patients and QKW and HL provided advice.

Corresponding author

Correspondence to Xianqin Zhang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee on human subject research at Huazhong University of Science and Technology (2014IECs066) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from the participants. All experiments involving animals were approved by the Ethics Committee on Animal Research of Huazhong University of Science and Technology (S672).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 184 kb)

Supplementary file2 (MP4 16493 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, D., Yuan, C., Liu, M. et al. Deficiency of SCAMP5 leads to pediatric epilepsy and dysregulation of neurotransmitter release in the brain. Hum Genet 139, 545–555 (2020). https://doi.org/10.1007/s00439-020-02123-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00439-020-02123-9

Navigation